SAN CLEMENTE, Calif., July 11, 2017 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced the time of its second quarter 2017 earnings release and conference call.
The Company will release its second quarter 2017 results on Wednesday, August 9, 2017 at approximately 4:00 p.m. EDT (1:00 p.m. PDT) and will be conducting a conference call concerning those results at 4:30 p.m. EDT (1:30 p.m. PDT) on Wednesday, August 9, 2017. The call can be accessed at (800) 936-9761, international (408) 774-4587, conference ID 52290938. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.
About ICU Medical, Inc.
ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical devices used in vascular therapy, and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical, Inc. can be found at www.icumed.com.
CONTACT: ICU Medical, Inc. Scott Lamb, Chief Financial Officer (949) 366-4227 ICR, Inc. John Mills, Partner (646) 277-1254


Britain Courts Anthropic Amid US Defense Department Dispute
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs 



